Gus Gazzard et al on behalf of the LiGHT Trial Study Group (2019) Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. [Accessed Nov 2019]